These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5094312)

  • 41. [Experimental research on the action of beta-adrenergic receptor blocking agents].
    Valora N; Fidanza A; Floridi S
    Arch Fisiol; 1969 Dec; 67(3):251-72. PubMed ID: 4394262
    [No Abstract]   [Full Text] [Related]  

  • 42. Interaction of beta-adrenergic blocking agents with noradrenaline in vascular smooth muscle.
    Mazurkiewicz-Kwilecki IM
    Eur J Pharmacol; 1970 Jul; 11(2):155-62. PubMed ID: 4317567
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of pindolol on the metabolic activities of adrenaline].
    Schmitt H; Lucet B
    C R Seances Soc Biol Fil; 1970; 164(11):2193-5. PubMed ID: 4399994
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 45. The influence of propranolol, INPEA, iproveratril and some 1-naphthylethylamine derivatives on the myocardial phosphorylase activity.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1970 Apr; 19(4):1221-7. PubMed ID: 4398008
    [No Abstract]   [Full Text] [Related]  

  • 46. Anti-arrhythmic, local anaesthetic, and adrenergic blocking activity of some beta-receptor antagonists.
    Hermansen K
    Br J Pharmacol; 1969 Mar; 35(3):476-86. PubMed ID: 5809739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 48. Tranquillizing effects of propranolol demonstrated in rats.
    Bainbridge JG; Greenwood DT
    Neuropharmacology; 1971 Jul; 10(4):453-8. PubMed ID: 4398456
    [No Abstract]   [Full Text] [Related]  

  • 49. The selectivity of -adrenergic compounds. II. Studies on the mimetic compound Salbutamol and the lytic compound practolol.
    Grana E; Mastelli OC; Zonta F; Lucchelli A; Santagostino MG
    Farmaco Sci; 1972 Oct; 27(10):842-54. PubMed ID: 4404432
    [No Abstract]   [Full Text] [Related]  

  • 50. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.
    Levy JV
    Eur J Pharmacol; 1968 Feb; 2(4):250-7. PubMed ID: 4384450
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 52. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-arrhythmic ancd local anaesthetic activity of some beta-receptor blocking compounds.
    Hermansen K
    Br J Pharmacol; 1968 Sep; 34(1):200P. PubMed ID: 4300140
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of adrenergic agents on carbohydrate metabolism of rat liver: activities of adenyl cyclase and glycogen phosphorylase.
    Newton NE; Hornbrook KR
    J Pharmacol Exp Ther; 1972 Jun; 181(3):479-88. PubMed ID: 5033014
    [No Abstract]   [Full Text] [Related]  

  • 55. Beta-blockers in hypertension.
    Wilkinson JC
    Br Med J; 1970 Dec; 4(5738):802. PubMed ID: 4395725
    [No Abstract]   [Full Text] [Related]  

  • 56. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
    Range H; Bischoff M; Siess M
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE; Izquierdo JA
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of LB-46, a new beta adrenergic blocking agent, on pulse and blood pressure at rest and after exercise in healthy volunteers.
    Mehta AB; Cooverji ND; Agrawal AB; Shah AC; Patnekar PN; Vora DD
    J Assoc Physicians India; 1971 Nov; 19(11):765-70. PubMed ID: 4399862
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparative studies with the beta-receptor blockaders LB 46 and propranolol in healthy persons using the isoproterenol test].
    Bender F; Dotterweich K
    Med Welt; 1971 Sep; 22(37):1444-6. PubMed ID: 4398359
    [No Abstract]   [Full Text] [Related]  

  • 60. [Influence of some drugs with adrenergic beta-receptor blocking action on the repolarization phase of the electrocardiogram of normal subjects].
    Barbaresi F; Volta G; Starcich R
    Folia Cardiol; 1969; 28(1):1-6. PubMed ID: 4391631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.